NCT06482073Recruiting
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (INTERCEPTioN for Suspected Lung Cancer)for Suspected Lung Cancer)
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
This study evaluates the effectiveness of tumor samples in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 25 Jun 2024
- Start date
- 24 Jun 2024
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Lung cancer
- NCT number
- NCT06482073
What you commit to
- Study type: Observational
- Planned participants: 250
- From 24 Jun 2024 to the primary completion date, 1 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior germline genetic testing with a 40+ multi-gene panel AND/OR prior somatic tissue (250+ gene) testing utilizing the tissue from the bronchoscopy or surgical resection
Other
- Individuals who have situations that would limit compliance with the study requirements
- Institutionalized (i.e. federal medical prison)
- Pregnant
Who the study is looking for
- Subject age 18 years and older
- Subject is scheduled/was scheduled for a bronchoscopy or surgical resection as part of standard of care
- Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
- Ability to provide blood or saliva sample
- Ability to provide archived tissue
- Subject is able to understand and adhere to study requirements and able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.